433 related articles for article (PubMed ID: 32222192)
1. Small molecules, big impact: 20 years of targeted therapy in oncology.
Bedard PL; Hyman DM; Davids MS; Siu LL
Lancet; 2020 Mar; 395(10229):1078-1088. PubMed ID: 32222192
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy in cancer.
Tsimberidou AM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
4. Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology.
Sabnis AJ; Bivona TG
Trends Mol Med; 2019 Mar; 25(3):185-197. PubMed ID: 30686761
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
6. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
Albin N; Mc Leer A; Sakhri L
Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
[TBL] [Abstract][Full Text] [Related]
7. Precision cancer medicine: the future is now, only better.
Tsimberidou AM; Eggermont AM; Schilsky RL
Am Soc Clin Oncol Educ Book; 2014; ():61-9. PubMed ID: 24857061
[TBL] [Abstract][Full Text] [Related]
8. [Targeted therapy in thyroid cancer: Towards a treatment card].
Lkhoyaali S; Benhmida S; Ait Elhaj M; Layachi M; Bensouda Y; Errihani H
Pathol Biol (Paris); 2015 Feb; 63(1):1-6. PubMed ID: 25555494
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology Developing First Clinical Trial.
Brower V
J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
[No Abstract] [Full Text] [Related]
10. [Individualization of anticancer therapy; molecular targets of novel drugs in oncology].
Regulska K; Stanisz B; Regulski M
Postepy Hig Med Dosw (Online); 2012 Nov; 66():855-67. PubMed ID: 23175342
[TBL] [Abstract][Full Text] [Related]
11. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
[TBL] [Abstract][Full Text] [Related]
12. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
13. Target therapy for metastatic breast cancer.
Rachdi H; Mokrani A; Batti R; Ayadi M; Chraiet N; Mezlini A
Tunis Med; 2018; 96(8-9):465-471. PubMed ID: 30430522
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer as a paradigm for precision oncology in solid tumours.
Schallenberg S; Merkelbach-Bruse S; Buettner R
Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
[TBL] [Abstract][Full Text] [Related]
15. [Targeted therapy in glioblastoma: update and perspectives].
Idbaih A; Duran-Peña A; Alentorn A
Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
[TBL] [Abstract][Full Text] [Related]
16. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeted therapy in prevalent tumors: learning from the past and future perspectives.
Metzger-Filho O; Moulin C; Awada A
Curr Clin Pharmacol; 2010 Aug; 5(3):166-77. PubMed ID: 20406173
[TBL] [Abstract][Full Text] [Related]
18. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
19. Lessons Learned: Dose Selection of Small Molecule-Targeted Oncology Drugs.
Bullock JM; Rahman A; Liu Q
Clin Cancer Res; 2016 Jun; 22(11):2630-8. PubMed ID: 27250934
[TBL] [Abstract][Full Text] [Related]
20. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
